Mochi's True Monthly Cost — What You Actually Pay
Mochi's advertised medication rate doesn't tell the full cost story. The effective monthly total depends on whether Mochi's membership fee is charged separately from the medication subscription — a distinction that significantly changes the comparison math.
Mochi Health — True Monthly Cost Breakdown (June 2026)
Providers Cheaper Than Mochi — Ranked by Sema Monthly Rate
Luma Health — Flat Rate, Named Pharmacy, No Commitment
$197/mo flat for compounded semaglutide at every dose from starting through maintenance year three. VialsRX (TX #35264) publicly named and verifiable at pharmacy.texas.gov. Wasef Health, PC clinical oversight. No contracts, cancel anytime. Annual total $2,364 — $204 less per year than Mochi's combined midpoint. Tirzepatide $297/mo flat.
Henry Meds — Lowest Annual Rate (Commitment Required)
~$145/mo semaglutide on annual billing — the lowest publicly disclosed rate in the legitimate compounded market. Tirzepatide ~$179/mo flat annual. Annual commitment required for the lowest price; less cancellation flexibility than month-to-month. Pharmacy not prominently named. Best choice for patients primarily minimizing annual cost and comfortable with annual billing.
Ro Body — Lower at Starting Dose, Higher at Maintenance
Ro's sema starts ~$145–$169/mo but increases with dose through titration — reaching $199–$229/mo at maintenance. Less than Mochi's combined total at all dose tiers. Insurance navigation for brand Wegovy available. Ro-owned pharmacy named. For patients at early titration, Ro is less expensive than Mochi; at maintenance, Ro and Luma Health are comparable while still below Mochi combined.
Hims — Medication Only, Lower Starting Price
Hims sema basic tier ~$149–$199/mo depending on plan. Less than Mochi's combined cost at most tiers. No coaching included. Pharmacy not prominently named for independent verification. Video consultations not offered for GLP-1. Cancellation friction reported. For medication-only price comparison, Hims is cheaper than Mochi at most dose levels.
Mochi Health — Benchmark (Medication + Membership)
~$179/mo medication + ~$35–$79/mo membership = ~$214–$258/mo effective combined total. RD coaching included — genuine value for engaged patients. Dose-tier pricing may increase at maintenance. Pharmacy not prominently named. Higher than all providers above when comparing total effective monthly cost.
Full Provider Comparison Table
| Provider | Sema (mo) | Tirz (mo) | Annual Sema | vs Mochi/yr | Coaching | Pharmacy Named | Commitment |
|---|---|---|---|---|---|---|---|
| Henry Meds | ~$145 | ~$179 | $1,740 | −$828 | No | No | Annual required |
| ★ Luma Health | $197 flat | $297 flat | $2,364 | −$204+ | No | ✓ VialsRX TX#35264 | None |
| Ro Body | $145–$229 | $199–$329 | $2,148–$2,748 | −$420 to +$180 | Plus/Premium | Ro-owned | None |
| Hims | $149–$199 | $249–$329 | $1,788–$2,388 | −$180 to −$780 | No | No | None |
| Mochi (combined) | ~$214–$258/mo | ~$249+/mo | ~$2,568–$3,096 | — | ✓ RD coaching | Not prominently | Verify |
| Found | $129–$199 | $199–$249 | $1,548–$2,388 | −$180 to −$1,020 | ✓ Included | Not prominently | None |
| Calibrate (ins.) | ~$25/mo brand | ~$25/mo brand | ~$1,649 + $300 | −$619 (ins. approved) | ✓ 4 RD sessions | Retail pharmacy | $1,649 upfront |
Frequently Asked Questions
What is the cheapest legitimate GLP-1 provider compared to Mochi?
On an annual basis, Henry Meds is the least expensive legitimate compounded GLP-1 platform compared to Mochi — approximately $145/month for semaglutide on annual billing vs Mochi's effective combined total of approximately $214–$258/month including membership. The annual savings switching from Mochi to Henry Meds is approximately $828 or more per year. The trade-off: Henry Meds requires annual billing commitment and doesn't prominently name its pharmacy. Luma Health is the next-cheapest at $197/month flat — $204+ per year less than Mochi's midpoint — with named pharmacy (VialsRX TX #35264), no annual commitment, and the same active GLP-1 molecule.
Why is Mochi more expensive than other GLP-1 platforms?
Mochi's higher effective monthly cost reflects two factors: (1) the RD coaching membership bundled with the medication subscription — registered dietitian services have real cost and real clinical value, especially for patients who engage consistently with nutrition guidance; and (2) dose-tier medication pricing that can increase as your titration progresses. Platforms like Luma Health, Henry Meds, Ro, and Hims operate medication-only or lower-overhead models without coaching infrastructure. The cost difference is a real service model difference, not a quality difference in the GLP-1 medication itself.
Is the semaglutide from cheaper providers the same as Mochi's?
Yes — pharmacologically. All legitimate compounded GLP-1 platforms prescribe compounded semaglutide using the same active pharmaceutical ingredient (semaglutide) at equivalent pharmacological doses. The STEP 1 trial data (14.9% average weight loss at 68 weeks with semaglutide 2.4 mg/week) applies to the molecule regardless of which licensed 503A compounding pharmacy prepared it or which platform prescribed it. Price differences between Mochi, Luma Health, Henry Meds, Ro, and Hims reflect business model choices — not differences in medication molecule, pharmacological activity, or clinical efficacy potential.
Is Mochi's RD coaching worth the extra cost?
If you will consistently attend and engage with RD coaching sessions, Mochi's higher price is clinically justifiable. Registered dietitian guidance — especially nutritional strategy for managing GLP-1 side effects, optimizing protein intake to preserve lean mass, and dietary adjustments for long-term weight maintenance — has documented benefit as an adjunct to GLP-1 medication. If you won't consistently use the coaching (and many patients don't attend regularly), you're paying $35–$79/month for services you don't receive. In that scenario, switching to a medication-only platform like Luma Health or Henry Meds and spending the savings on quarterly RD sessions through your local health system or a telehealth dietitian service may provide more value.
How do I switch from Mochi to a cheaper provider without a treatment gap?
Start your new provider's intake with 2–3 weeks of Mochi medication remaining. Provide your current weekly dose (semaglutide or tirzepatide) during intake. Your new provider prescribes at your current dose — no re-titration, no dose restart. Wait for your new medication to arrive with a confirmed tracking number before canceling Mochi. Get written confirmation of Mochi cancellation with the effective date. On your next weekly injection day, draw your current dose from the new vial. The transition preserves treatment continuity and protects your weight loss progress.
What is Mochi's membership fee for?
Mochi's membership fee covers access to their behavioral health coaching platform, which includes registered dietitian sessions, accountability check-ins, and behavioral support tools. The membership is a separate charge from the medication subscription — combining both gives the effective monthly total of approximately $214–$258/month for semaglutide patients. Patients who actively use RD sessions and coaching tools find the membership valuable. Patients primarily seeking medication access without coaching services pay for infrastructure they don't use. Verify current Mochi membership pricing at joinmochi.com before enrolling — rates and bundling structures change periodically.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- Rubino DM, et al. Effect of Continued Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA. 2021;325(14):1414–1425. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- Mochi Health. Official Website. joinmochi.com
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov